72686450Microsoft Office PowerPointOn-screen Show (4:3)1256200falseFonts Used8Theme1Slide Titles6ArialGenevaＭＳ ＰゴシックMyriad ProSymbolTimes New RomanWingdingsヒラギノ角ゴ Pro W3AETC_Master_Template_061510Elbasvir + Grazoprevir +/- Ribavirin in Treatment-Naïve HCV GT 2, 4, 5, or 6 C-SCAPEElbasvir + Grazoprevir +/- RBV in Treatment-Naïve GT 2, 4, 5 or 6 C-SCAPE Study: FeaturesElbasvir + Grazoprevir +/- RBV in Treatment-Naïve GT 2, 4, 5 or 6 C-SCAPE Study: Study Design for GT 1Elbasvir + Grazoprevir +/- RBV in Treatment-Naïve GT 2, 4, 5 or 6 C-SCAPE Study: Baseline CharacteristicsElbasvir + Grazoprevir +/- RBV in Treatment-Naïve GT 2, 4, 5 or 6 C-SCAPE Study: ResultsElbasvir + Grazoprevir +/- RBV in Treatment-Naïve GT 2, 4, 5 or 6 C-SCAPE Study: ConclusionsHMCfalsefalsefalse16.0000